Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Protein-Protein Interfaces02:04

Protein-Protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Photoredox-Catalyzed Lysine C(sp<sup>3</sup>)-H Functionalization for Peptide Editing.

Journal of the American Chemical Society·2026
Same author

Small Molecule Catalyst for Peptide Synthesis.

Journal of the American Chemical Society·2025
Same author

From Concepts to Inhibitors: A Blueprint for Targeting Protein-Protein Interactions.

Chemical reviews·2025
Same author

Reengineering of a Proteomimetic Pan-Ras Inhibitor into a Ras Degrader.

Angewandte Chemie (International ed. in English)·2025
Same author

C2230, a preferential use- and state-dependent CaV2.2 channel blocker, mitigates pain behaviors across multiple pain models.

The Journal of clinical investigation·2024
Same author

A peptidomimetic modulator of the Ca<sub>V</sub>2.2 N-type calcium channel for chronic pain.

Proceedings of the National Academy of Sciences of the United States of America·2023

関連する実験動画

Updated: May 30, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

阻害剤設計のための螺旋状タンパク質インターフェースの評価

Brooke N Bullock1, Andrea L Jochim, Paramjit S Arora

  • 1Department of Chemistry, New York University, New York, New York 10003, USA.

Journal of the American Chemical Society
|August 18, 2011
PubMed
まとめ

この研究では,タンパク質-タンパク質相互作用 (PPI) の合成阻害剤の設計を導くために螺旋状タンパク質インターフェースを分析しています. 発見は,ヘリックス媒介の複合形成を理解することによって,新しい治療法を開発するのに役立ちます.

科学分野:

  • 構造生物学 構造生物学とは
  • 薬剤化学 薬剤化学について
  • 計算生物学とは,計算生物学である.

背景:

  • アルファヘリクスが媒介するタンパク質とタンパク質の相互作用 (PPI) は,生物学的プロセスにおいて極めて重要です.
  • これらの相互作用のための合成阻害剤の設計は,インタフェースダイナミクスの理解が限られているため,依然として困難です.
  • 既存のヘリックス・ミミティックは,生物学的応用では広く採用されていない.

研究 の 目的:

  • タンパク質データバンクにおける螺旋状タンパク質のインターフェースを体系的に分析する.
  • ヘリクスがタンパク質複合体の形成をどのように媒介するかを包括的に概説する.
  • PPIを標的とした新種の合成阻害剤の合理的な設計を導く.

主な方法:

  • プロテインデータバンク (PDB) のヘリクル状タンパク質インターフェースの完全なデータセットの分析.
  • 複雑な形成に関与するヘリクスの主要な特徴と相互作用パターンの特定.
  • 新しく特定されたタンパク質複合体のクラスの実験的評価.

主要な成果:

  • 多様なヘリコースインターフェースアーキテクチャとインタラクションモードの特徴化.
  • ヘリックス模倣阻害剤の薬効ポケットと設計戦略の特定.

さらに関連する動画

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

関連する実験動画

Last Updated: May 30, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

  • 新しい複合体の実験的評価を通じて,計算上の発見の検証.

    • 結論:

    • 螺旋的なインターフェースの体系的な分析は,構造ベースの薬剤設計のための重要な洞察を提供します.
    • この研究は,ヘリックス模倣設計と生物学的応用の間のギャップを埋めています.
    • この発見は,様々なPPIに対する標的型合成阻害剤の開発を容易にする.